Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLO1 | Q04760 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21744787 | 0.85 | GLO1 (0.33) | GLO1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL4056561 | 0.81 | CTDSP1 (0.34) | GLO1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL19755024 | 0.80 | GLO1 (0.34) | GLO1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL31379461 | 0.79 | BTN3A1 (0.31) | — | |
| SCHEMBL2219015 | 0.78 | ALDH1A1 (0.38) | GLO1ALDH1A1LMNAHSD17B10MAPT | |
| SCHEMBL6220404 | 0.77 | GAA (0.43) | ALDH1A1LMNAHSD17B10MAPTNPSR1 | |
| SCHEMBL1085871 | 0.73 | MAPT (0.33) | ALDH1A1MAPT | |
| SCHEMBL21391880 | 0.73 | ALOX15 (0.33) | — | |
| SCHEMBL22774724 | 0.73 | GAA (0.41) | ALDH1A1MAPT | |
| SCHEMBL28558851 | 0.71 | ALDH1A1 (0.37) | GLO1ALDH1A1LMNAHSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025036407-A1 | ALDH-ACTIVABLE FUNTIONALIZED MONOSACCARIDES, PHARMACEUTICAL COMPOSITIONS, AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | SURIO THERAPEUTICS CO. LTD. (CN) | 2025-02-20 | — | — | WO | disclosed |